Patent: 5,372,808
✉ Email this page to a colleague
Summary for Patent: 5,372,808
Title: | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
Abstract: | Methods for the treatment of cell proliferation disorders, viral infections, and other conditions without causing significant side effects normally associated with interferon therapy, involving administering to a patient in need thereof a therapeutically effective amount of consensus human leukocyte interferon are disclosed. Also disclosed are pharmaceutical compositions of consensus human leukocyte interferon. |
Inventor(s): | Blatt; Lawrence M. (Ventura, CA), Taylor; Milton W. (Bloomington, IN) |
Assignee: | Amgen Inc. (Thousand Oaks, CA) |
Application Number: | 07/868,916 |
Patent Claims: | see list of patent claims |
Details for Patent 5,372,808
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Kadmon Pharmaceuticals Llc | INFERGEN | interferon alfacon-1 | Injection | 103663 | 10/06/1997 | ⤷ Sign Up | 2011-12-13 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,372,808
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 932641 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9321229 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9206707 | ⤷ Sign Up |
Ukraine | 44223 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |